SGO 2023 Conference Coverage on VuMedi
SGO 2023 Placebo-Controlled Randomized Phase 3 Trial: Dostarlimab in Combination With Chemo for the Treatment of Primary Advanced or Recurrent Endometrial Cancer
By
SGO 2023 Conference Coverage on VuMedi
FEATURING
Mansoor Raza Mirza
By
SGO 2023 Conference Coverage on VuMedi
FEATURING
Mansoor Raza Mirza
Comments 0
Login to view comments.
Click here to Login
